1. Home
  2. WLY vs LGND Comparison

WLY vs LGND Comparison

Compare WLY & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WLY
  • LGND
  • Stock Information
  • Founded
  • WLY 1807
  • LGND 1987
  • Country
  • WLY United States
  • LGND United States
  • Employees
  • WLY N/A
  • LGND N/A
  • Industry
  • WLY Books
  • LGND Biotechnology: Pharmaceutical Preparations
  • Sector
  • WLY Consumer Discretionary
  • LGND Health Care
  • Exchange
  • WLY Nasdaq
  • LGND Nasdaq
  • Market Cap
  • WLY 2.3B
  • LGND 2.0B
  • IPO Year
  • WLY N/A
  • LGND 1992
  • Fundamental
  • Price
  • WLY $39.11
  • LGND $103.76
  • Analyst Decision
  • WLY
  • LGND Strong Buy
  • Analyst Count
  • WLY 0
  • LGND 8
  • Target Price
  • WLY N/A
  • LGND $144.71
  • AVG Volume (30 Days)
  • WLY 448.9K
  • LGND 118.3K
  • Earning Date
  • WLY 06-17-2025
  • LGND 05-08-2025
  • Dividend Yield
  • WLY 3.60%
  • LGND N/A
  • EPS Growth
  • WLY N/A
  • LGND N/A
  • EPS
  • WLY 0.75
  • LGND N/A
  • Revenue
  • WLY $1,703,491,000.00
  • LGND $181,488,000.00
  • Revenue This Year
  • WLY N/A
  • LGND $17.68
  • Revenue Next Year
  • WLY $1.13
  • LGND $18.69
  • P/E Ratio
  • WLY $52.13
  • LGND N/A
  • Revenue Growth
  • WLY N/A
  • LGND 53.40
  • 52 Week Low
  • WLY $34.85
  • LGND $77.43
  • 52 Week High
  • WLY $53.96
  • LGND $129.90
  • Technical
  • Relative Strength Index (RSI)
  • WLY 26.04
  • LGND 44.63
  • Support Level
  • WLY $40.25
  • LGND $98.90
  • Resistance Level
  • WLY $41.12
  • LGND $103.17
  • Average True Range (ATR)
  • WLY 0.97
  • LGND 3.05
  • MACD
  • WLY -0.49
  • LGND -0.27
  • Stochastic Oscillator
  • WLY 7.78
  • LGND 31.94

About WLY John Wiley & Sons Inc.

John Wiley & Sons Inc is one of the world's greatest publishers and a trusted leader in research and learning. Its industry-principal content, services, platforms, and knowledge networks are tailored to meet the evolving needs of its customers and partners, including researchers, students, instructors, professionals, institutions, and corporations. The company empowers knowledge-seekers to transform today's obstacles into tomorrow's brightest opportunities. For more than two centuries, the company has been delivering on its timeless mission to unlock human potential.

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Share on Social Networks: